One-year-old girl treated as plans to inject DNA-cutting technology directly into patients' bodies take shape.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Adoptive cell transfer: new perspective treatment in veterinary oncology
Acta Veterinaria Scandinavica Open Access 11 October 2018
-
A proteomic analysis of an in vitro knock-out of miR-200c
Scientific Reports Open Access 02 May 2018
-
One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans
European Journal of Human Genetics Open Access 30 November 2017
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
06 November 2015
This story has been updated with information about the plans of the company Editas.
10 November 2015
The story has been updated to include the company Cellectis, which developed the gene-editing technology used to treat Layla.
References
Tebas, P. et al. N. Engl. J. Med. 370, 901–910 (2014).
Sharma, R. et al. Blood 126, 1777-1784 (2015).
Additional information
Related links
Related links
Related links in Nature Research
Mini enzyme moves gene editing closer to the clinic 2015-Apr-01
Gene-editing method tackles HIV in first clinical test 2014-Mar-05
CRISPR technology leaps from lab to industry 2013-Dec-03
Related external links
Rights and permissions
About this article
Cite this article
Reardon, S. Leukaemia success heralds wave of gene-editing therapies. Nature 527, 146–147 (2015). https://doi.org/10.1038/nature.2015.18737
Published:
Issue date:
DOI: https://doi.org/10.1038/nature.2015.18737
This article is cited by
-
Adoptive cell transfer: new perspective treatment in veterinary oncology
Acta Veterinaria Scandinavica (2018)
-
One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans
European Journal of Human Genetics (2018)
-
A proteomic analysis of an in vitro knock-out of miR-200c
Scientific Reports (2018)
-
CRISPR and the Rebirth of Synthetic Biology
Science and Engineering Ethics (2017)
-
CRISPR as a driving force: the Model T of biotechnology
Monash Bioethics Review (2016)
